Cargando…

Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer

Breast cancer (BC) is the most common malignancy in female, but the role of androgen receptor (AR) in triple-negative breast cancer (TNBC) is still unclear. This study aimed to exam the performance of innovative biomarkers for AR positive TNBC in diagnosis and therapies. Four datasets (GSE42568, GSE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Pengjun, Guo, Qiaonan, Yao, Qingzhi, Chen, Jianpeng, Lin, Jianqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604295/ https://www.ncbi.nlm.nih.gov/pubmed/34797837 http://dx.doi.org/10.1371/journal.pone.0254283

Ejemplares similares

Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC
por: Guo, Qiaonan, et al.
Publicado: (2022)

Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer
por: Qiu, Pengjun, et al.
Publicado: (2021)

A pyroptosis-associated gene risk model for predicting the prognosis of triple-negative breast cancer
por: Qiu, Pengjun, et al.
Publicado: (2022)

Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer
por: Cao, Jintao, et al.
Publicado: (2021)

An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer
por: Qiu, Pengjun, et al.
Publicado: (2022)

Identification of an exosome-related signature associated with prognosis and immune infiltration in breast cancer
por: Guo, Qiaonan, et al.
Publicado: (2023)

Construction and validation of a transient receptor potential-related long noncoding RNA signature for prognosis prediction in breast cancer patients
por: Guo, Qiaonan, et al.
Publicado: (2023)

Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer
por: Liu, Zundong, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related long non-coding RNA signature and personalized therapeutic strategy of breast cancer patients
por: Guo, Qiaonan, et al.
Publicado: (2022)

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020)

Circular RNA hsa_circ_0131242 Promotes Triple-Negative Breast Cancer Progression by Sponging hsa-miR-2682
por: Li, Yueting, et al.
Publicado: (2020)

LHC MDs 3163, 3164, and 3166: Injection oscillations throughout the cycle
por: Timko, Helga, et al.
Publicado: (2019)

3163 A Systematic Review of Research Competency Assessments for Clinical Researchers
por: Ianni, Phillip A, et al.
Publicado: (2019)

Cyclin B2 (CCNB2) Stimulates the Proliferation of Triple-Negative Breast Cancer (TNBC) Cells In Vitro and In Vivo
por: Wu, Shuai, et al.
Publicado: (2021)

CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a bioinformatics study
por: Li, An-hai, et al.
Publicado: (2022)

The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer
por: Delgir, Soheila, et al.
Publicado: (2021)

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
por: Speers, Corey, et al.
Publicado: (2017)

Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
por: Brumec, Maša, et al.
Publicado: (2021)

Triple-Negative Breast Cancer circRNAome Reveals Hsa_circ_0072309 as a Potential Risk Biomarker
por: Magalhães, Leandro, et al.
Publicado: (2022)

Requirement for CCNB1 in mouse spermatogenesis
por: Tang, Ji-Xin, et al.
Publicado: (2017)

Long non-coding FAM201A accelerates the tumorigenesis and progression of colorectal cancer through miR-3163/MACC1 axis
por: Zeng, Lifeng, et al.
Publicado: (2022)

Adaptation to Hypoxia May Promote Therapeutic Resistance to Androgen Receptor Inhibition in Triple-Negative Breast Cancer
por: Jinna, Nikita, et al.
Publicado: (2022)

Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis
por: Zeng, Yinzhen, et al.
Publicado: (2022)

Z-Guggulsterone Induces Cell Cycle Arrest and Apoptosis by Targeting the p53/CCNB1/PLK1 Pathway in Triple-Negative Breast Cancer
por: Wu, Yihao, et al.
Publicado: (2023)

Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells
por: Jia, Ming, et al.
Publicado: (2016)

MEX3A promotes nasopharyngeal carcinoma progression via the miR-3163/SCIN axis by regulating NF-κB signaling pathway
por: Xiang, Xin-xin, et al.
Publicado: (2022)

Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells
por: Liu, Huiyong, et al.
Publicado: (2020)

CCNB2 as a potential biomarker of bladder cancer via the high throughput technology
por: Zhang, Lei, et al.
Publicado: (2023)

CCNB1 is involved in bladder cancer pathogenesis and silencing CCNB1 decelerates tumor growth and improves prognosis of bladder cancer
por: Wang, Xue-Xuan, et al.
Publicado: (2023)

Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1
por: Lin, Zhenghong, et al.
Publicado: (2015)

MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents
por: Yang, Bin, et al.
Publicado: (2019)

Hsa_circ_0001925 promotes malignant progression in triple‐negative breast cancer via miR‐1299/YY1 axis
por: Shen, Bin‐jie, et al.
Publicado: (2023)

Metformin suppresses lung adenocarcinoma by downregulating long non-coding RNA (lncRNA) AFAP1-AS1 and secreted phosphoprotein 1 (SPP1) while upregulating miR-3163
por: Qiu, Caiyu, et al.
Publicado: (2022)

Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
por: Zhang, Li, et al.
Publicado: (2015)

Hsa-Mir-320c, Hsa-Mir-200c-3p, and Hsa-Mir-449c-5p as Potential Specific miRNA Biomarkers of COPD: A Pilot Study
por: Cerón-Pisa, Noemi, et al.
Publicado: (2022)

Prognostic value of hsa-mir-299 and hsa-mir-7706 in hepatocellular carcinoma
por: Wang, Fenglin, et al.
Publicado: (2018)

Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
por: Astvatsaturyan, Kristine, et al.
Publicado: (2018)

CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor
por: Xiang, Bin, et al.
Publicado: (2023)

Effect of miR-205 on proliferation and migration of thyroid cancer cells by targeting CCNB2 and the mechanism
por: Wang, Xin, et al.
Publicado: (2020)

Rare Case of BCOR::CCNB3 Sarcoma of Bone
por: Arai, Yumi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n790t3irstqo589n6jurah8vnv